封面
市场调查报告书
商品编码
1747574

感染监测解决方案市场按产品/服务、感染疾病类型、最终用户和地区划分

Infection Surveillance Solutions Market, by Product and Services, by Infection Type by End User and By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格
简介目录

感染监测解决方案市场规模预计在 2025 年达到 8.92 亿美元,预计到 2032 年将达到 22.596 亿美元,2025 年至 2032 年的复合年增长率为 14.2%。

分析范围 分析详细信息
基准年 2024 市场规模(2025年) 8.92亿美元
效能数据 2020-2024 预测期 2025-2032
预测期内的复合年增长率(2025-2032) 14.20% 预计金额(2032年) 22.596亿美元

感染监测解决方案是一种软体,可协助医院和其他医疗机构向州和联邦当局报告病患资料。感染监测解决方案用于医疗产业,收集医院内感染数据并研究感染模式,以控制社区内感染的传播。医院内感染是感染疾病。该软体会在感染疾病爆发时向医院的网路通讯协定(IP) 发出警报,使医院内感染 (HAI) 专家和护理人员能够及时救治感染疾病患者,避免感染疾病爆发。感染监测解决方案是一种程序,可帮助医疗机构有效管理医院内感染 (HAI)。肺炎、胃肠道疾病、尿道感染感染疾病以及某些手术相关的感染疾病是医院内感染疾病(HAI) 的主要类型。医院内感染疾病(HAI) 的高发生率是世界各国政府关注的重点问题,因此各国政府都制定了有效管理和减少医院内感染 (HAI) 发生的政策。

市场动态

预计在预测期内,市场主要企业越来越多地采用非直接成长策略,例如透过收购来扩大产品系列,将推动市场成长。例如,2019年5月,软体公司RLDatix宣布收购iContracts,后者是一家为多个行业提供云端基础的合约、合规和收益管理软体的供应商。此次收购将RLDatix的病患安全平台与iContracts先进的策略管理功能结合,使组织首次能够透过部署动态策略和程序来解决事件的根本原因。

本报告的主要特点

  • 本报告对全球感染监测解决方案市场进行了详细分析,并以 2024 年为基准年,展示了预测期(2025-2032 年)的市场规模和复合年增长率。
  • 它还强调了每个细分市场的潜在商机,并解释了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 全球感染监测解决方案市场的主要企业会根据以下参数进行分析,例如公司概况、产品系列、主要亮点、财务绩效和策略。
  • 透过本报告的见解,负责人和企业经营团队可以就未来的产品发布、合作伙伴关係、市场扩张和行销策略做出明智的决策。
  • 「全球感染监测解决方案市场」报告涉及该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员可以透过用于分析全球感染监测解决方案市场的各种策略矩阵来简化决策。

目录

第一章 分析目标与前提条件

  • 分析目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map (COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 影响分析
  • 主要亮点
  • 产品发布
  • 技术进步
  • PEST分析
  • 监管情景
  • 企业合併与收购(M&A)

第四章全球感染监测解决方案市场(按产品和服务划分)(2020-2032)

  • 软体
  • 服务

5. 全球感染监测解决方案市场(按感染疾病类型划分)(2020-2032 年)

  • 手术部位感染疾病
  • 血流感染疾病
  • 尿道感染

6. 全球感染监测解决方案市场(按最终用户划分)(2020-2032 年)

  • 医院
  • 诊所
  • 门诊手术中心
  • 其他(专门中心等)

7. 全球感染监测解决方案市场(按地区) (2020-2032)

  • 北美洲
      • 美国
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 欧洲
      • 英国
      • 德国
      • 义大利
      • 法国
      • 西班牙
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • ASEAN
      • 澳洲
      • 韩国
      • 其他亚太地区
  • 中东
      • GCC
      • 以色列
      • 其他中东地区
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第八章 竞争态势

  • Baxter
  • BD
  • STERIS
  • Getinge AB
  • Medtronic
  • Koninklijke Philips NV
  • Abbott
  • Medexter Healthcare
  • Asolva
  • GOJO Industries, Inc.
  • Wolters Kluwer NV
  • VigiLanz Corporation
  • RLDatix
  • Roper Technologies, Inc.
  • Health Outcomes Worldwide
  • OpGen, Inc.
  • Urovant Sciences
  • Premier

第九章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI1699

Infection Surveillance Solutions Market is estimated to be valued at USD 892 Mn in 2025 and is expected to reach USD 2,259.6 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 14.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 892 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 14.20% 2032 Value Projection: USD 2,259.6 Mn

Infection surveillance solution is software that helps healthcare facilities such as hospitals and others to report data related to patients, to the state and federal authorities. Infection surveillance solutions are used in the healthcare industry to collect data on nosocomial infections to study the pattern of infections and regulate their spread in the community. Nosocomial infections are infections that are spread to people from hospitals or healthcare centers. This software alerts hospital Internet Protocol (IPs) in case of infection occurrence so that HAI specialists and nurses can treat patients suffering from the infection in order to avoid outbreaks of infection. Infection surveillance solutions are programs, which help in the effective management of the Healthcare-Acquired Infections (HAIs) in healthcare facilities. Pneumonia, gastrointestinal illness, urinary tract infections, primary bloodstream infections, and infections related to some surgery are the few major Healthcare-Acquired Infections (HAIs). High incidences of Healthcare-Acquired Infections (HAIs) is a major concern for government across the globe, and hence, various governments have outlined policies to effectively manage and reduce incidences of HAIs.

Market Dynamics

Increasing adoption of inorganic growth strategies, such as acquisitions by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in May 2019, RLDatix, a software company, announced that they had acquired iContracts, a provider of cloud-based contract, compliance, and revenue management software for multiple industries. The acquisition brings together the RLDatix patient safety platform with iContracts leading policy management capabilities to allow organizations, for the first time, to take action on the root causes of incidents through the implementation of policies and procedures that are dynamic.

Key features of the study

  • This report provides in-depth analysis of the global infection surveillance solutions market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global infection surveillance solutions market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study are Baxter, BD, STERIS, Getinge AB, Medtronic, Koninklijke Philips N.V., Abbott, Medexter Healthcare, Asolva, GOJO Industries, Inc., Wolters Kluwer N.V., VigiLanz Corporation, RLDatix, Roper Technologies Inc., Health Outcomes Worldwide, OpGen, Inc., Urovant Sciences, and Premier
  • Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global infection surveillance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global infection surveillance solutions market

Market Segmentation

  • Global Infection Surveillance Solutions Market, By Products and Services
    • Software
    • On-Premises
    • Web-Based
    • Services
    • Support & Maintenance
    • Training & Consulting
  • Global Infection Surveillance Solutions Market, By Infection Type
    • Surgical Site Infections
    • Blood Stream Infections
    • Urinary Tract Infections
  • Global Infection Surveillance Solutions Market, By End User
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
    • Other (Specialty Center, etc.)
  • Global Infection Surveillance Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles
    • Baxter
    • BD
    • STERIS
    • Getinge AB
    • Medtronic
    • Koninklijke Philips N.V.
    • Abbott
    • Medexter Healthcare
    • Asolva
    • GOJO Industries, Inc.
    • Wolters Kluwer N.V.
    • VigiLanz Corporation
    • RLDatix
    • Roper Technologies, Inc.
    • Health Outcomes Worldwide
    • OpGen, Inc.
    • Urovant Sciences
    • Premier

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Products and Services
    • Market Snapshot, By Infection Type
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Key Highlights
  • Product Launch
  • Technological Advancements
  • PEST Analysis
  • Regulatory Scenario
  • Mergers and Acquisitions

4. Global Infection Surveillance Solutions Market, By 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
      • On-Premises
      • Web-Based
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
      • Support & Maintenance
      • Training & Consulting

5. Global Infection Surveillance Solutions Market, By Infection Type, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Surgical Site Infections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  • Blood Stream Infections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  • Urinary Tract Infections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

6. Global Infection Surveillance Solutions Market, By End User, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segments Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  • Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  • Ambulatory Surgical Center
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)
  • Others (Specialty Center, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Million)

7. Global Infection Surveillance Solutions Market, By Region, 2020 - 2032, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Million)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Million)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Baxter
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • BD
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • STERIS
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Getinge AB
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Koninklijke Philips N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medexter Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Asolva
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • GOJO Industries, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Wolters Kluwer N.V.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • VigiLanz Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • RLDatix
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Roper Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Health Outcomes Worldwide
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • OpGen, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Urovant Sciences
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Premier
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us